I am Sad to Announce that My Brother Brian is Leaving Georgetown to Lead the Radiosurgery Program at the University of South Florida.
I have Worked with Him for Over 20 Years!
He Will be Missed.
The Future of Tampa General Hospital's Radiosurgery Program is Bright!
Saw a Patient with Unfavorable Intermediate Risk Prostate Cancer in Follow-up Yesterday.
He was 89 yo and 12 years post SBRT treatment (36.35 Gy in 5 fractions).
His AUA score was a 2 and his PSA was 0.03 ng/ml.
Made My Day! 😀
I love Being a Prostate Cancer Doctor!
Mary-Kate Lawlor, MS3 and I had a Great Time Taking Care of Prostate Cancer Patients Today!
She Wants to be an “Oncologist”
Which Specialty Should She Apply For?
Clinical Oncology: Article in Press!
Safety and Efficacy of Ultra-hypofractionation in Node Positive Prostate Cancer
Prostate 35-36.25 Gy in 5 fx
Involved Node(s) 35 Gy in 5 fx
Elective Pelvic Nodes 25 Gy in 5 fx
Telkhade et al.
Nicole Elyse Hodgins, MS3 and I Had a Great Time Working On A Prostate SBRT Manuscript Today!
Born in Michigan.
She is Going Into Rad Onc and Wants to Match in the Midwest.
Which Program Would You Recommend?
Looking forward to ESTRO 2020
This house believes that Elective nodal radiotherapy should be performed for high risk prostate cancer
Peter Hoskin and Thomas Zilli
Speakers:
For:
Mack Roach,
Against:
Alberto Bossi
Gert De Meerleer
Melisa Pasli (East Carolina, MS4) and I Just Had a Great Time Discussing her RadOnc Research!
She Majored in Polymer Chemistry at North Carolina State and Finished First in her Class!
She is presenting at ABS tomorrow on GammaTile Cs-131 Brachytherapy.
Stop by to Say Hello. 😎
Today is My Brother Brian's Last Day at Georgetown.
25 Years at a Single Institution is a Long Time!
He Starts at Tampa General Hospital on Monday Morning.
He Will Be Missed!
At Least I can Still Follow Him On Twitter. 😊
@radiosurgerybr1
Last Day at 3rd ICC in Mumbai:
I Would Like to Thank Drs Maneesh Singh and Priyamvada Maitre from Tata Memorial for Showing Me Around Their Amazing City with Accuray India’s Support.
The Future of RadOnc in India is Bright!
View of Marine Drive from Hanging Gardens
Madhav Patel (Georgetown MS3) and I Just Had a Great Time Discussing QOL Following Prostate SBRT!
He is Going Into Rad Onc and Wants to Do Away Rotation in Southern California.
He has Authored 40 Publications and is a Great Stats Guy!
Which Program Would You Recommend?
A Day In the Life of Georgetown Radiation Oncology:
Alexander Campbell (MS4; Kansas) and Marc Farah (MS3; GT).
Alex is a Mechanical Engineer and Pilot who is Applying for Rad. Onc.
Marc is Interested in Oncology
I Received My Second Pfizer Shot Today!
I am Grateful to Medstar Health and Georgetown University Hospital for the Amazing Job Everyone Has Done to Keep Us Safe During the Pandemic!
@MedStarHealth
@MedStarGUH
@MedStarIQS
We are pleased to inform you that we have appointed a new
#AccurayExchange
Advisory Board, led by
@SbrtSean
! This new leadership team will build on the legacy of its predecessors by bringing fresh ideas & perspectives to continue to grow and strengthen our user community.
Sarthak Shah, MS3 Spent Sunday Morning with Me Analyzing QOL Outcomes Following ADT and SBRT!
His Work on Hematospermia Following SBRT has Already Been Published.
He Is Going Into Rad Onc and Wants to Match Near his Family in New Jersey.
Which Program Would You Recommend?
ESTRO 2022 in Copenhagen:
Please Stop By and See Dr. Dylan Conroy's Poster:
Take Home Point:
Technical Challenges Such as Hip Replacements Can Lead to Higher than Expected Rates of Toxicities and Late Local Recurrences (Median time = 8 yrs) Following Prostate SBRT!
Dosimetric Feasibility of NVB-Sparing SBRT with Periprostatic Hydrogel Spacer for Localized Prostate Cancer to Preserve Erectile Function
Hwang et al. Columbia University
Honored to Present Our Poster at AUA 2023 in Chicago:
Preferences for Key Attributes of Clinically Available Androgen Deprivation Therapies Among Men with Prostate Cancer
Article In Press! Red Journal
SBRT and HDR Brachytherapy Boost in Combination with IMRT for localized prostate cancer: a single-institution propensity score matched analysis
Curves Look Pretty Similar to Me!
Red Journal: Article in Press!
Hypofractionated Post-Prostatectomy Radiotherapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase I/II trial
Wages et al. University of Virginia
Simran Jatar, MS3 Studying ADT Induced Gynecomastia on a Long Weekend in the Georgetown RadOnc Department!
Proud Houstonian!
Interested in Pediatric Radiation Oncology!
Prostate SBRT Treatment Planning:
Commonly, the PTV is Formed by Expanding the Prostate Volume 3 mm Posteriorly.
To Achieve Rectal Dose Constraints, Commonly the “True” Posterior Margin on Such Plans are 1-2 mm or Less.
Have You Noticed This In Your Prostate SBRT Plans?
Looking Forward to ASCO-GU in San Fran.
PACE-A: Phase 3 Trial comparing SBRT to Surgery for Localized Prostate Cancer —Primary Endpoint Analysis.
Presenter: Nicholas Van As
5 yr Biochemical PFS:
Nadir + 2 ng/ml for SBRT and >0.2 ng/ml for Prostatectomy.
Fair Comparison?